Moscow: The British medical journal The Lancet has acknowledged the effectiveness of the Russian vaccine over 91%.
According to the details, significant progress has been made in the field of Russian-made corona vaccine Sputnik V. The famous British medical journal The Lancet has published a report on the third phase of clinical trials of the Russian vaccine.
The report states that Sputnik V is a highly effective vaccine with a rate of over 91%.
According to the report, data from clinical trials of 19,866 volunteers, including 4,902 in the placebo group, show that the overall effectiveness of the Russian-made vaccine is 91.6%.
The trials showed that the Russian vaccine was effective in 91.8% of the 2,144 volunteers over the age of 60.
Research published in The Lancet concludes that the Russian vaccine has been shown to be 100% effective in protecting patients from the coronavirus.
Alexander Ginsberg, director of the Gamaleya Research Institute in Moscow, which develops the Sputnik V vaccine, said the results of the third phase of clinical trials of the vaccine were a major breakthrough in the global war on the World War I epidemic.